イスラエルのトップ肺癌医師と価格を比較。こちらで最適なマッチングを見つけてください
ご要望と予算に基づいて最適な医師を厳選いたします
医学的監修者 Fahad Mawlood
医学編集者・データサイエンティストトップ医師
3
イスラエル
レビュー
14000+
実際の患者より
個別化された治療計画を無料で取得し、最良のオプションを選択してください。コミットメント不要 · サービス料金なし
Thoracic Surgeon
Oncologist. Specialist in Medical Oncology and Radiotherapy
Deputy Head of the Department of Oncology
海外のクリニックを選ぶことはストレスフルです。800,000名以上の患者をサポートしたBookimedは、お客様の懸念を理解しています。信頼できる医師、最高の価格品質オプション、複雑なケースの解決策を見つける方法を知っています。すべての段階でお客様をご案内いたします。
ヤン・マツィイフスキー
医療コーディネーターチーム責任者
4300+件以上の患者の旅をガイド
Bookimedで3年
Israelの142名の患者が今月当社を通じて医師を見つけました
2分のクイズ
目標、予算、スケジュールをお聞かせください
人間のマッチング + AI
アルゴリズムがマッチングを見つけ、コーディネーターが適合性を確認します
オプション準備完了
価格、パッケージ、日程を比較。コーディネーターとチャット
選択肢に迷っていますか？
治療をガイド
医療訓練を受けた専属コーディネーター
| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|
Lung cancer care in Israel involves a multidisciplinary team led by medical oncologists, thoracic surgeons, and radiotherapists. Experts like Professor Ofer Merimsky and Professor Nir Peled specialize in personalized immunotherapy and innovative chemo-radiotherapy protocols within JCI-accredited centers to improve patient results.
Bookimed Expert Insight: Leading Israeli specialists often hold dual certifications or rare combinations of expertise. For example, Dr. Raphael Pfeffer is board-certified in both oncology and radiology. This allows a single expert to oversee both the tumor biology and the high-tech imaging required for precise radiation planning.
Patient Consensus: Patients often mention how comfortable they feel when doctors explain the whole process in simple terms. One patient noted that the coordination between the surgeon and the oncologist made them feel their care was a joint effort.
Lung cancer doctors in Israel specialize in personalized treatments using molecular genetic profiling and immunotherapy. Experts like Dr. Nir Peled at Herzliya Medical Center and Dr. Ari Raphael at Sourasky Medical Center tailor therapies based on genomic sequencing to target specific tumor mutations.
Bookimed Expert Insight: Israeli specialists often hold dual qualifications in oncology and biology. Prof. Jair Bar and Prof. Raanan Berger both hold PhDs in molecular biology. This allows them to translate laboratory genomic data directly into personalized clinical protocols for advanced lung cancer cases.
Patient Consensus: Patients often feel relieved when specialists review their tumor genetics to suggest targeted drugs. They notice a clear focus on finding specific treatments that work for their unique cancer stage.
Israeli lung cancer doctors lead global research in immunotherapy and genomic medicine. Specialists like Dr. Nir Peled and Dr. Ari Raphael chair international committees and lead innovative molecular trials. These doctors integrate real-time research with clinical care to provide personalized therapies for advanced thoracic malignancies.
Bookimed Expert Insight: Israeli oncology centers like Sheba and Sourasky operate dedicated translational research units within the hospital. This means researchers like Dr. Raanan Berger and Dr. Yaacov Lawrence can immediately apply lab findings to patient care. Patients benefit from this integration because the most senior specialists often serve as principal investigators for international phase I-III clinical trials.
Patient Consensus: Patients emphasize the importance of asking about genetic testing and immunotherapy trials before beginning standard care. They felt more confident when doctors clearly explained how newer research protocols could work alongside traditional surgery or radiation.
Thoracic surgeons in Israel perform advanced surgeries using minimally invasive VATS and Da Vinci robotic systems. Specialists like Dr. Lael Anson Best at Rambam Medical Center have completed 1,000+ complex procedures. They focus on lung-sparing techniques like segmentectomy to preserve healthy tissue and speed up recovery.
Bookimed Expert Insight: Israeli thoracic surgeons often integrate molecular genetics into surgical planning. Dr. Jair Bar at Sheba Medical Center heads a unit focusing on immunotherapy and genetics. This ensures that surgery is part of a personalized plan, especially for patients with advanced or treatment-resistant cancer.
Patient Consensus: Many patients prioritize asking about lung-sparing options like segmentectomy over traditional lobectomy to maintain better breathing capacity. They noticed that while recovery is faster with robotic surgery, managing post-operative fatigue and drains remains a vital step.
Specialists in Israel determine lung cancer treatment plans through multidisciplinary tumor boards where surgeons, oncologists, and radiologists collaborate. They use genomic profiling and T-cell sequencing to identify specific mutations, ensuring every patient receives a personalized therapy roadmap based on their unique biology.
Bookimed Expert Insight: Israeli lung cancer specialists often hold dual certifications in oncology and radiotherapy. For example, Dr. Raphael Pfeffer at Assuta and Dr. Jair Bar at Sheba are board-certified in both. This dual expertise allows one doctor to manage both radiation and drug therapy. This integration usually leads to faster transitions between treatment phases compared to separate departments.
Patient Consensus: Patients often mention how quickly doctors move from the first consultation to a full treatment plan. Many were surprised that a single specialist could coordinate both their chemotherapy and radiation sessions efficiently.